RenovoRx Sees Q4 Loss Forecast of $0.08 and 1,150% Revenue Surge
RenovoRx, Inc. is forecast to post a $0.08 per share quarterly loss, marking a 33.3% year-over-year change, in its upcoming report. The company’s revenues are projected at $0.5 million, representing a 1,150% increase from the year-ago quarter.
1. Quarterly Loss Forecast
RenovoRx is expected to report a quarterly loss of $0.08 per share for the period ended December 2025, representing a 33.3% year-over-year change in per-share results.
2. Revenue Growth Projection
The company forecasts revenues of $0.5 million for the same quarter, marking a 1,150% increase from the year-ago quarter.
3. Consensus Estimate Trends
Analyst consensus for the upcoming quarter’s EPS and revenue has held steady over the past 30 days, indicating limited recent revisions ahead of the earnings release.
Related News
UXIN
Uxin to Launch 5,000-Vehicle Chongqing Superstore in 2026 Expansion Drive
UXIN•
HOOD
Robinhood Secures $3B Wells Fargo TradePMR Team, CFO to Present May 27
HOOD•
SPY
SpaceX S-1 Filing Reveals $4.7B Q1 Revenue, $1.94B Operating Loss
SPY•
ING
ING-backed euro stablecoin consortium grows to 37 banks, eyes H2 launch
ING•
TGT
Target CEO Highlights Under-$10 Toy Sales Surge Despite High Costs
TGT•
Sources
F